EFM
IRWD icon

E Fund Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

E Fund Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.8K Sell
21,556
-5,674
-21% -$21.9K ﹤0.01% 477
2026
Q1 		$95.6K Buy
+27,230
New +$112K ﹤0.01% 471
2025
Q1 		– Sell
-16,746
Closed -$74.2K – 418
2024
Q4 		$74.2K Sell
16,746
-8,739
-34% -$35.5K ﹤0.01% 385
2024
Q3 		$105K Buy
25,485
+2,143
+9% +$11.5K 0.01% 340
2024
Q2 		$152K Sell
23,342
-24,755
-51% -$175K 0.01% 301
2024
Q1 		$419K Buy
48,097
+10,410
+28% +$126K 0.03% 201
2023
Q4 		$431K Sell
37,687
-7,209
-16% -$71.3K 0.03% 186
2023
Q3 		$432K Buy
44,896
+5,907
+15% +$57.9K 0.03% 149
2023
Q2 		$415K Buy
38,989
+3,670
+10% +$39.4K 0.03% 159
2023
Q1 		$372K Sell
35,319
-366
-1% -$4.1K 0.03% 193
2022
Q4 		$442K Sell
35,685
-7,619
-18% -$86.4K 0.04% 159
2022
Q3 		$449K Buy
43,304
+6,039
+16% +$68.5K 0.04% 144
2022
Q2 		$430K Buy
37,265
+14,279
+62% +$168K 0.04% 174
2022
Q1 		$289K Buy
22,986
+7,384
+47% +$84.6K 0.01% 207
2021
Q4 		$182K Buy
15,602
+1,472
+10% +$18.1K 0.01% 271
2021
Q3 		$185K Buy
+14,130
New +$183K 0.01% 236
2021
Q1 		$137K Buy
+12,254
New +$129K 0.01% 226

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

E Fund Management's IRWD Position: Q2 2026 in Review

E Fund Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 21% in Q2 2026, selling an estimated $21.9K and leaving 21,556 shares worth $90.8K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

E Fund Management first reported a position in IRWD in Q1 2021 and has held it in 17 quarters since. The position peaked at $449K in Q3 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • E Fund Management held 21,556 shares of Ironwood Pharmaceuticals worth $90.8K as of Q2 2026.
  • E Fund Management sold 5,674 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $21.9K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #477 holding.
  • E Fund Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and has held it in 17 quarters since.
  • E Fund Management's Ironwood Pharmaceuticals position peaked at $449K in Q3 2022.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.